Magplasma
1 known investors
MagPlasma develops plasma-based processes to replace conventional thermal heating in applications from airborne and surface disinfection to manufacturing. Its BZAP product is a portable breathing-zone air sterilization device that captures and disinfects exhaled contagions.
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Homeland Security | Phase II | 2022 | $997.2K |
| Department of Homeland Security | Phase I | 2021 | $148.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Magplasma do?
- MagPlasma develops plasma-based processes to replace conventional thermal heating in applications from airborne and surface disinfection to manufacturing. Its BZAP product is a portable breathing-zone air sterilization device that captures and disinfects exhaled contagions.
- Who are Magplasma's investors?
- Magplasma's investors include Michigan Rise.